Listen to the news
A new research on corona virus says that the corona vaccine is required to be given to 50 percent of the country's population, if the vaccine capacity is 100 percent. By doing this, the chain of infection can be broken and high levels of epidemics can be avoided.
There are many authors of this research, it was prepared by American scientists and printed in the American Journal of Preventive Medicine. This research states that the coverage and capacity of a vaccine are two important components for formulating a disease prevention policy.
Vaccine coverage refers to the percentage of people in the population who have been vaccinated, and the vaccine potential means the percentage of the disease is reduced by the vaccine effect in the vaccinated group compared to the unvaccinated group.
In many countries, work is going on fast on the Corona vaccine, so that the world can be run as before. Bruce Y. Lee, chief investigator at the City University of New York, says that even if a vaccine is made, it doesn't mean you can live your old life back, as it was before the epidemic.
Lee said that the vaccine is just like another product, which, after use, will have to be seen to see if it helps reduce the disease. Research believes that the vaccine should have at least 70 percent capacity and at least 80 percent to prevent disease without other measures.
Research states that the vaccine capacity limit may increase by 70 percent when the vaccine coverage falls by 75 percent and the vaccine capacity will increase by 80 percent when the coverage falls by 60 percent. Whenever the vaccine coverage falls by 50 percent, it will not be possible to end the high level of the epidemic.
As of August 25, there were 173 Kovid-19 cases in the world on separate clinical trials. This data is given according to the draft landscape of the World Health Organization's COVID-19 candidate vaccine. In India, AstraZeneca-Oxford is jointly producing the vaccine which will be produced at the Serum Institute in Pune.
Brandon Yan of the University of California says that to increase the vaccination rate, whether it is for the long term or for the short term, intervention will be needed. He further said that we need a public health campaign which includes public health officers, health care providers and the local community.
In addition, he said that an active primary care strategy would be needed to address patients' concerns and where and how to administer the vaccine.